Market revenue in 2023 | USD 10.4 million |
Market revenue in 2030 | USD 29.1 million |
Growth rate | 15.9% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Abcam PLC, Takara Bio Inc, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, HTG Molecular Diagnostics Inc, Meridian Bioscience, New England Biolabs, Norgen Biotek, System Biosciences, Amoy Diagnostics, EntroGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mirna sequencing and assay market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 80.77% in 2023. Horizon Databook has segmented the India mirna sequencing and assay market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
In India, the miRNA sequencing and assay market are likely to show great potential in the future owing to presence of global players through their subsidiaries and focus of government & nongovernment organizations to spread awareness about miRNA sequencing among end users.
For instance, the National Centre for Biological Sciences (NCBS) is a professional body involved in promoting, encouraging, and developing biology-based studies. The primary objective of NCBS is to create and share knowledge between students, research fellows, and post-doctoral fellows.
In addition, the well-distributed network of key players in India is leading to higher and faster adoption of the miRNA sequencing techniques. This factor along with the demand for better-advanced instruments and kits renders the future outlook of miRNA sequencing and assay market very promising & attractive in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the India mirna sequencing and assay market , including forecasts for subscribers. This country databook contains high-level insights into India mirna sequencing and assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account